Alaunos Therapeutics, Inc.
TCRT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,679 | -$35,140 | -$37,730 | -$78,751 |
| Dep. & Amort. | $2 | $2,315 | $2,759 | $2,597 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $435 | $2,800 | $3,528 | $10,774 |
| Change in WC | -$729 | -$6,254 | $870 | $3,141 |
| Other Non-Cash | $0 | $6,137 | $1,341 | $771 |
| Operating Cash Flow | -$4,971 | -$30,142 | -$29,232 | -$61,468 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$197 | -$216 | -$3,323 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $1,543 | $23 | $0 |
| Investing Cash Flow | $0 | $1,346 | -$193 | -$3,323 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$18,105 | -$8,333 | $25,000 |
| Stock Issued | $0 | $92 | $14,724 | $0 |
| Stock Repurch. | $0 | $0 | -$45 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$125 | $21 | $776 |
| Financing Cash Flow | $0 | -$18,138 | $6,367 | $25,776 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,971 | -$46,934 | -$23,058 | -$39,015 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,062 | $52,996 | $76,054 | $115,069 |
| End Cash | $1,091 | $6,062 | $52,996 | $76,054 |
| Free Cash Flow | -$4,971 | -$30,339 | -$29,448 | -$64,791 |